These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16296718)

  • 1. Growth factor delivery for bone tissue repair: an update.
    Varkey M; Gittens SA; Uludag H
    Expert Opin Drug Deliv; 2004 Nov; 1(1):19-36. PubMed ID: 16296718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized delivery of growth factors for bone repair.
    Luginbuehl V; Meinel L; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2004 Sep; 58(2):197-208. PubMed ID: 15296949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical aspects of tissue-engineered therapy for bone regeneration.
    Doll B; Sfeir C; Winn S; Huard J; Hollinger J
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):173-98. PubMed ID: 11693960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone tissue engineering by gene delivery.
    Kofron MD; Laurencin CT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):555-76. PubMed ID: 16790291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward delivery of multiple growth factors in tissue engineering.
    Chen FM; Zhang M; Wu ZF
    Biomaterials; 2010 Aug; 31(24):6279-308. PubMed ID: 20493521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-based gene therapy strategies for bone regeneration.
    Phillips JE; Gersbach CA; García AJ
    Biomaterials; 2007 Jan; 28(2):211-29. PubMed ID: 16928397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
    Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
    Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration.
    Liu J; Xu L; Li Y; Ma J
    Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of local bone regeneration - Protein versus gene therapy.
    Fischer J; Kolk A; Wolfart S; Pautke C; Warnke PH; Plank C; Smeets R
    J Craniomaxillofac Surg; 2011 Jan; 39(1):54-64. PubMed ID: 20434921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterials of drug delivery systems for tissue regeneration.
    Tabata Y
    Methods Mol Biol; 2005; 300():81-100. PubMed ID: 15657480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
    Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
    Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biotechnol Lett; 2009 Dec; 31(12):1817-24. PubMed ID: 19690804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone repair: new developments in growth factor delivery systems and their mathematical modeling.
    Lauzon MA; Bergeron E; Marcos B; Faucheux N
    J Control Release; 2012 Sep; 162(3):502-20. PubMed ID: 22889715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing proteins for bone targeting.
    Gittens SA; Bansal G; Zernicke RF; Uludağ H
    Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-based tissue engineering in bone and cartilage repair.
    Wozney JM; Seeherman HJ
    Curr Opin Biotechnol; 2004 Oct; 15(5):392-8. PubMed ID: 15464367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
    Liu HW; Chen CH; Tsai CL; Hsiue GH
    Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of growth factors for bone regeneration.
    Yun YR; Jang JH; Jeon E; Kang W; Lee S; Won JE; Kim HW; Wall I
    Regen Med; 2012 May; 7(3):369-85. PubMed ID: 22594329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
    Han D; Liu W; Ao Q; Wang G
    Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factors and bone regeneration: how much bone can we expect?
    Nauth A; Ristevski B; Li R; Schemitsch EH
    Injury; 2011 Jun; 42(6):574-9. PubMed ID: 21489530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.